Perpetua Medical’s subsidiary ES-Medical reaches agreement with its main supplier and develops next-generation cleaning system for TEE probes
Perpetua Medical announces changes to its management team
INTERIM REPORT JANUARY – JUNE 2026
Perpetua Medical has entered a letter of intent regarding the acquisition of a majority stake in ES-Medical AB
Resolutions from the Annual General Meeting 2024 in Pepetua Medcial
Perpetua Medical is offered a loan facility of up to SEK 25 million
Perpetua Medical publishes interim report January – March 2024
NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL)
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
